Forbes

A public health expert examines the science behind colostrum and breaks down the social media hype on that wellness product.

A doctor explains a new survey from the Health Management Academy: 55% of Medicaid enrollees are unaware of work requirements that take effect January 2027.

Microsoft releases its second-generation quantum chip. Ultrasound could replace pacemakers. And why you shouldn’t skip breakfast.

Forecasts remain central to healthcare policy evaluation. And so, their accuracy is particularly important in relation to possible expansion of GLP-1 coverage.

Engineered fluorescent nanobodies that work inside living cells can label multiple proteins in different colors at once, revealing real-time cellular activity.

Two college students lost their best friend to ovarian cancer. Here's how they turned grief into a growing movement to honor her legacy.

CBS news correspondent Natalie Morales talks about mother-in-law Kay Rhodes's diagnosis of early-onset Alzheimer's disease back in 2000 and what's different now.

Ambient AI is transforming clinical documentation. But what happens when patients can audit the record, not the source?

The growth of influencers in the longevity medicine space is rapidly expanding, but also the need for physician, regulatory and public scrutiny.

Upheaval at the U.S. Preventive Services Task Force may reshape coverage of preventive care by insurance, possibly leading to removal of previously covered items.

Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 million more VC funding at a $3.4 billion valuation, Forbes has learned.

Healthcare costs are rising 18% for small-and mid-sized businesses as employers grapple with a surge in inflation and medical expenses, a Morgan Health report shows.

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors should trust the model

As interest in peptide therapy continues to grow, CeliaRx is positioning itself as a trusted destination for personalized, physician-guided peptide care.

In this week’s edition of InnovationRx, we look at breakthroughs from ASCO, Harrison.ai's U.S. expansion, Clear's move into healthcare and more.